BAYER AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.95 EUR | -0.19% |
|
-4.12% | -22.84% |
| Jun. 19 | Global markets live: Vodafone, Bayer, Apple, Microsoft, Qualcomm... |  |
| Jun. 19 | Bayer's Crop Science Business Developing AI to Kill Weeds | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-08-06
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
26
EUR
Average target price
36.18
EUR
Spread / Average Target
+39.16%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.84% | 27.37B | |
| +51.99% | 798B | |
| +40.87% | 633B | |
| -5.72% | 356B | |
| +18.94% | 328B | |
| +11.07% | 304B | |
| +16.58% | 244B | |
| +2.86% | 227B | |
| +10.91% | 216B | |
| +7.59% | 166B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer to Set Up a 600 Million Yuan Facility for Enhanced Capacity in China
